
palliative treatment nonresectable lung cancer upper hemibody 
perfusion chlorimine (short-acting alkylating agent).  experience 
five cases. 
   method discussed providing palliative treatment 
patients nonresectable lung cancer 
means administering short-acting alkylating agent 
upper half body temporarily occluding 
circulation lower half body.  proper 
selection patients awareness potential 
complications, procedure appears safe effective. 
